Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitogen-activated protein kinases (MAPKs) are activated in response to various extracellular stimuli, and their activities are regulated by upstream activating kinases and protein phosphatases such as MAPK phosphatases (MKPs). We report the identification and characterization of a novel MKP termed
SKRP1
(
SAPK pathway-regulating phosphatase 1
). It contains an extended active site sequence motif conserved in all MKPs but lacks a Cdc25 homology domain. Immunoblotting analysis revealed that
SKRP1
is constitutively expressed, and its transcripts of 4.0 and 1.0 kb were detected in almost tissues examined.
SKRP1
was highly specific for c-Jun N-terminal kinase (JNK) in vitro and effectively suppressed the JNK activation in response to tumor necrosis factor alpha or thapsigargin. Endogenous
SKRP1
was present predominantly in the cytoplasm and co-localized with JNK. However,
SKRP1
does not bind directly to its target JNK, but co-precipitation of
SKRP1
with the MAPK kinase
MKK7
, a JNK activator, was found in vitro and in vivo. Furthermore, we found that
SKRP1
did not interfere with the co-precipitation of
MKK7
with JNK. Together, our findings indicate that
SKRP1
interacts with its physiological substrate JNK through
MKK7
, thereby leading to the precise regulation of JNK activity in vivo.
...
PMID:A novel dual specificity phosphatase SKRP1 interacts with the MAPK kinase MKK7 and inactivates the JNK MAPK pathway. Implication for the precise regulation of the particular MAPK pathway. 1195 61
Stress-activated protein kinase (SAPK) pathway-regulating phosphatase 1 (
SKRP1
) has been identified as a member of the mitogen-activated protein kinase (MAPK) phosphatase (MKP) family that interacts physically with the MAPK kinase (MAPKK)
MKK7
, a c-Jun N-terminal kinase (JNK) activator, and inactivates the MAPK JNK pathway. Although these findings indicated that
SKRP1
contributes to the precise regulation of JNK signaling, it remains to be elucidated how
SKRP1
is integrated into this pathway. We report that
SKRP1
also plays a scaffold role for the JNK signaling, judged by the following observations.
SKRP1
selectively formed the stable complexes with
MKK7
but not with
MKK4
and biphasically regulated the
MKK7
activity and
MKK7
-induced gene transcription in vivo. Co-precipitation analysis between
SKRP1
and
MKK7
-activating MAPKK kinases (MAPKKKs) revealed that
SKRP1
also interacted with the MAPKKK, apoptosis signal-regulating kinase 1 (ASK1), but not with MAP kinase kinase kinase 1 (MEKK1). Consistent with these findings,
SKRP1
expression increased the ASK1-
MKK7
complexes in a dose-dependent manner and specifically enhanced the activation of
MKK7
by ASK1. Thus, our findings are, to our knowledge, the first evidence to show that an MKP also functions as a scaffold protein for the particular MAPK signaling.
...
PMID:Scaffold role of a mitogen-activated protein kinase phosphatase, SKRP1, for the JNK signaling pathway. 1195 62